Slough, United Kingdom

Stephen Robert Mack



Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovations of Stephen Robert Mack

Introduction

Stephen Robert Mack is a notable inventor based in Slough, GB, recognized for his contributions to the field of medicinal chemistry. With a total of four patents to his name, Mack has made significant strides in developing innovative compounds that serve as kinase inhibitors, which are crucial in treating various medical conditions.

Latest Patents

Mack's latest patents include a series of quinoxaline and quinoline derivatives that act as selective inhibitors of PI3 kinase enzymes. These compounds are designed to be beneficial in medicine, particularly for treating inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, or ophthalmic conditions. Another notable patent involves fused thiophene derivatives, which are also selective inhibitors of PI3 kinase enzymes and share similar therapeutic applications.

Career Highlights

Stephen Robert Mack is currently employed at UCB Pharma, S.A., where he continues to innovate and contribute to the field of drug development. His work focuses on creating effective treatments that address complex medical issues, showcasing his commitment to improving patient outcomes.

Collaborations

Mack collaborates with esteemed colleagues, including Rikki Peter Alexander and George Martin Buckley, to advance research and development in his field. Their combined expertise fosters a productive environment for innovation.

Conclusion

Stephen Robert Mack's contributions to medicinal chemistry through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…